These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 12771508)

  • 1. Inflammation versus immunoregulation: what is the key to the development of an effective antiallergy vaccine?
    Wohlleben G; Erb KJ
    Pathobiology; 2002-2003; 70(5):270-6. PubMed ID: 12771508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel vaccines protecting against the development of allergic disorders: a double-edged sword?
    Erb KJ; Wohlleben G
    Curr Opin Immunol; 2002 Oct; 14(5):633-43. PubMed ID: 12183166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA vaccines for the prevention and treatment of allergy.
    Chua KY; Kuo IC; Huang CH
    Curr Opin Allergy Clin Immunol; 2009 Feb; 9(1):50-4. PubMed ID: 19532092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotechnology-based allergy diagnosis and vaccination.
    Bhalla PL; Singh MB
    Trends Biotechnol; 2008 Mar; 26(3):153-61. PubMed ID: 18222557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 15-lipoxygenase metabolites play an important role in the development of a T-helper type 1 allergic inflammation induced by double-stranded RNA.
    Jeon SG; Moon HG; Kim YS; Choi JP; Shin TS; Hong SW; Tae YM; Kim SH; Zhu Z; Gho YS; Kim YK
    Clin Exp Allergy; 2009 Jun; 39(6):908-17. PubMed ID: 19260872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation and Evaluation of Prophylactic mRNA Vaccines Against Allergy.
    Weiss R; Scheiblhofer S; Thalhamer J
    Methods Mol Biol; 2017; 1499():123-139. PubMed ID: 27987146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses.
    Trujillo-Vargas CM; Mayer KD; Bickert T; Palmetshofer A; Grunewald S; Ramirez-Pineda JR; Polte T; Hansen G; Wohlleben G; Erb KJ
    Clin Exp Allergy; 2005 Aug; 35(8):1003-13. PubMed ID: 16120081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atopic disorders: a vaccine around the corner?
    Wohlleben G; Erb KJ
    Trends Immunol; 2001 Nov; 22(11):618-26. PubMed ID: 11698223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of probiotic supplementation for the first 6 months of life on allergen- and vaccine-specific immune responses.
    Taylor AL; Hale J; Wiltschut J; Lehmann H; Dunstan JA; Prescott SL
    Clin Exp Allergy; 2006 Oct; 36(10):1227-35. PubMed ID: 17014429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hybrid molecule resembling the epitope spectrum of grass pollen for allergy vaccination.
    Linhart B; Hartl A; Jahn-Schmid B; Verdino P; Keller W; Krauth MT; Valent P; Horak F; Wiedermann U; Thalhamer J; Ebner C; Kraft D; Valenta R
    J Allergy Clin Immunol; 2005 May; 115(5):1010-6. PubMed ID: 15867859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the MHC II presentation pathway in allergy vaccine development.
    Rhyner C; Kündig T; Akdis CA; Crameri R
    Biochem Soc Trans; 2007 Aug; 35(Pt 4):833-4. PubMed ID: 17635159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal, liposome-adjuvanted cockroach allergy vaccines made of refined major allergen and whole-body extract of Periplaneta americana.
    Meechan P; Tungtrongchitr A; Chaisri U; Maklon K; Indrawattana N; Chaicumpa W; Sookrung N
    Int Arch Allergy Immunol; 2013; 161(4):351-62. PubMed ID: 23689057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, engineering and in vitro evaluation of MHC class-II targeting allergy vaccines.
    Crameri R; Flückiger S; Daigle I; Kündig T; Rhyner C
    Allergy; 2007 Feb; 62(2):197-206. PubMed ID: 17298430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of allergen-specific immunotherapy and novel ways for vaccine development.
    Jutel M; Van de Veen W; Agache I; Azkur KA; Akdis M; Akdis CA
    Allergol Int; 2013 Dec; 62(4):425-33. PubMed ID: 24153333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergic reactions after immunization.
    Kelso JM
    Ann Allergy Asthma Immunol; 2013 Jun; 110(6):397-401. PubMed ID: 23706707
    [No Abstract]   [Full Text] [Related]  

  • 16. Production of Rice Seed-Based Allergy Vaccines.
    Takagi H; Takaiwa F
    Methods Mol Biol; 2016; 1403():713-21. PubMed ID: 27076162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel immunotherapy vaccine development.
    Jutel M; Akdis CA
    Curr Opin Allergy Clin Immunol; 2014 Dec; 14(6):557-63. PubMed ID: 25304230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different profile of CD8+ effector T cells induced in Der p 1-allergic and naïve mice by DNA vaccination.
    Draghi M; Jarman ER; Grifantini R; Galli-Stampino L; Lamb JR; Valiante NM; Grandi G
    Eur J Immunol; 2002 Dec; 32(12):3720-8. PubMed ID: 12516566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic mRNA Vaccination against Allergy Confers Long-Term Memory Responses and Persistent Protection in Mice.
    Hattinger E; Scheiblhofer S; Roesler E; Thalhamer T; Thalhamer J; Weiss R
    J Immunol Res; 2015; 2015():797421. PubMed ID: 26557723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of dendritic and epithelial cells as master regulators of allergic airway inflammation.
    Lambrecht BN; Hammad H
    Lancet; 2010 Sep; 376(9743):835-43. PubMed ID: 20816550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.